US Equity

But this one has been relentless so far.
We're still stuck in a trading range.
The stock's longer-term price history points to something much more optimistic.
Considering the lack of bullish interest, the stock appears ready to roll over again.
Potential takeover targets are popping up in the sector.
We're not sure when the stock will break out on the topside of its consolidation, but it could be soon. Longs should be patient.
And here's a gateway into how to read the September minutes in order to discern the answers.
This move in health care takes your breath away.
Congress could eventually fail to raise the U.S. debt-ceiling.
Take advantage of elevated option premiums to gain long exposure to biotech.

Columnist Conversations

Yum's getting ridiculous again because you have to wait for the call tomorrow and no one knows what will be sa...
My view is that the bulls have it wrong and that the preoccupation with the price momentum over the last two d...
Does the YUM miss call into question the optimism regarding the Chinese consumer?


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.